bluebird bio, Inc. 4
4 · bluebird bio, Inc. · Filed Feb 2, 2017
Insider Transaction Report
Form 4
Mandell James
Director
Transactions
- Exercise/Conversion
Common Stock
2017-01-31$21.43/sh+8,000$171,440→ 9,000 total - Exercise/Conversion
Stock Option (right to buy)
2017-01-31+8,000→ 4,000 totalExercise: $21.43Exp: 2024-01-08→ Common Stock (8,000 underlying) - Sale
Common Stock
2017-01-31$75.04/sh−8,000$600,322→ 1,000 total
Footnotes (3)
- [F1]This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on December 13, 2016.
- [F2]The range in prices for the transaction reported on this line was $75.00 to $75.20. The average weighted price was $75.0402. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]This option vests ratably over three years in annual installments, commencing on January 8, 2014.